KUVATRIS THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
KUVATRIS THERAPEUTICS, INC. reported Increase (Decrease) in Accrued Liabilities of -$858.89 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2026-01-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-01-14
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $41.08K.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $0.00.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-03-31 was -$899.97K.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2023-12-31 was $920.87K.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $46.46K, a 80.53% decline from fiscal 2022.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $238.62K, a 135.08% increase from fiscal 2021.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $101.50K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $41.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | $41.08K derived: sum of 2 quarters · filed 2026-01-14 | -$858.89K 10-Q · filed 2026-01-14 | $61.98K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | -$899.97K 10-Q · filed 2024-09-20 | $20.90K derived: sum of 3 quarters · filed 2024-09-20 | $10.00K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-03-31 | -$899.97K 10-Q · filed 2024-05-13 | $20.90K derived: sum of 2 quarters · filed 2024-05-13 | $10.00K derived: sum of 3 quarters · filed 2026-01-14 | -$98.86K derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-12-31 | $920.87K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $909.97K derived: sum of 2 quarters · filed 2026-01-14 | $801.12K derived: sum of 3 quarters · filed 2026-01-14 | $46.46K 10-K · filed 2024-03-11 |
| 2023-09-30 | -$10.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | -$119.75K derived: sum of 2 quarters · filed 2026-01-14 | -$874.41K 10-Q · filed 2026-01-14 | -$2.03M derived: sum of 4 quarters · filed 2026-01-14 |
| 2023-06-30 | -$108.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-20 | -$863.52K 10-Q · filed 2024-09-20 | -$2.02M derived: sum of 3 quarters · filed 2024-09-20 | -$1.71M derived: sum of 4 quarters · filed 2024-09-20 |
| 2023-03-31 | -$754.66K 10-Q · filed 2024-05-13 | -$1.91M derived: sum of 2 quarters · filed 2024-05-13 | -$1.60M derived: sum of 3 quarters · filed 2024-05-13 | -$712.71K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$846.01K derived: sum of 2 quarters · filed 2024-03-11 | $41.95K derived: sum of 3 quarters · filed 2024-03-11 | $238.62K 10-K · filed 2024-03-11 |
| 2022-09-30 | $308.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-16 | $1.20M derived: sum of 2 quarters · filed 2023-11-16 | $1.39M 10-Q · filed 2023-11-16 | $1.50M derived: sum of 4 quarters · filed 2023-11-16 |
| 2022-06-30 | $887.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.08M 10-Q · filed 2023-08-09 | $1.19M derived: sum of 3 quarters · filed 2023-08-09 | $1.09M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $196.67K 10-Q · filed 2023-05-15 | $302.35K derived: sum of 2 quarters · filed 2023-05-15 | $198.12K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $105.68K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.45K derived: sum of 2 quarters · filed 2023-03-30 | $101.50K 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$104.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$4.18K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $100.05K 10-Q · filed 2022-09-30 |